Zobrazeno 1 - 10
of 68
pro vyhledávání: '"S. Abogunrin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Value in Health. 25:S3-S4
Publikováno v:
Annals of Oncology. 33:S1575-S1576
Autor:
Heather Burnett, Hemangi Panchmatia, Olga Ovcinnikova, S. Abogunrin, Ajibade O Ashaye, Mehul Dalal
Publikováno v:
Future oncology (London, England). 18(4)
Plain language summary Peripheral T-cell lymphoma (PTCL) is an aggressive cancer that develops from white blood cells called T cells, which are an important part of the immune system. There is limited knowledge on the impact PTCL has on patients and
Publikováno v:
Value in Health. 25:S485
Publikováno v:
Value in Health. 25:S366
Publikováno v:
Value in Health. 25:S14
Systematic literature reviews provide rigorous assessments of clinical, cost-effectiveness, and humanistic data. Accordingly, there is a growing trend worldwide among healthcare agencies and decision-makers to require them in order to make informed d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9d11acbe0019ba2340251187dc83c50
https://doi.org/10.1101/2021.09.30.462652
https://doi.org/10.1101/2021.09.30.462652
Publikováno v:
Value in Health. 25:S205-S206
Autor:
S. Abogunrin, Ajibade Ashaye, Sandy Srinivas, Despina Thomaidou, Joseph C. Cappelleri, Lucile Serfass, Krishnan Ramaswamy, Giovanni Zanotti, Kyle Fahrbach, Andrew Clair
Publikováno v:
Future Oncology. 15:2175-2190
The optimal dosing schedule to maintain the effectiveness of sunitinib for metastatic renal cell carcinoma – while reducing toxicity – remains an important clinical question. A meta-analysis of randomized trials and observational studies assessed